ENSC · Company research
Ensysce Biosciences, Inc. Common Stock (ENSC): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Ensysce Biosciences (ENSC) Edges Higher: Shares Gain 2.19% to $0.44 - Growth ETF - https://www.dars.gov.et/ | Ensysce Biosciences (ENSC) Edges Higher: Shares Gain 2.19% to $0.44 - Growth ETF https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 7, 2026 | neutral | 0 | 0.6 |
| ENSC News | ENSYSCE BIOSCIENCES INC (NASDAQ:ENSC) - ChartMill | ENSC News | ENSYSCE BIOSCIENCES INC (NASDAQ:ENSC) ChartMill | View source ↗ | ChartMill | Oct 3, 2026 | neutral | 0 | 0.6 |
| ENSC Forecast — Price Target — Prediction for 2027 - TradingView | ENSC Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Sep 29, 2026 | neutral | 0 | 0.6 |
| Ensysce (ENSC) Notches +1.27% Gain — Bulls Tighten Grip 2026-09-17 - Fear Greed Index - https://www.siam.in/ | Ensysce (ENSC) Notches +1.27% Gain — Bulls Tighten Grip 2026-09-17 - Fear Greed Index https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Sep 17, 2026 | neutral | 0 | 0.6 |
| An opioid study from Ensysce is fully enrolled to test overdose protection - Stock Titan | An opioid study from Ensysce is fully enrolled to test overdose protection Stock Titan | View source ↗ | Stock Titan | Aug 31, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: Director at $ENSC Buys 508,614 Shares | ENSC Stock News - Quiver Quantitative | Insider Purchase: Director at $ENSC Buys 508,614 Shares | ENSC Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 18, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: Director at $ENSC Buys 508,614 Shares - Moomoo | Insider Purchase: Director at $ENSC Buys 508,614 Shares Moomoo | View source ↗ | Moomoo | Aug 18, 2026 | neutral | 0 | 0.6 |
| Ensysce Biosciences (ENSC) director buys stock and converts debt - Stock Titan | Ensysce Biosciences (ENSC) director buys stock and converts debt Stock Titan | View source ↗ | Stock Titan | Aug 18, 2026 | neutral | 0 | 0.6 |
| Ensysce Biosciences Completes Cy Biopharma Acquisition and Secures Up to $77 Million Private Financing - Yahoo Finance | Ensysce Biosciences Completes Cy Biopharma Acquisition and Secures Up to $77 Million Private Financing Yahoo Finance | View source ↗ | Yahoo Finance | Aug 6, 2026 | neutral | 0 | 0.6 |
| Let's uncover which stocks are experiencing notable gaps during today's session. - ChartMill | Let's uncover which stocks are experiencing notable gaps during today's session. ChartMill | View source ↗ | ChartMill | Aug 6, 2026 | neutral | 0 | 0.6 |
| Ensysce Biosciences Inc (NASDAQ: ENSC) Share Price, ENSC Stock News, ENSC Share Price & Updates - Kalkine | Ensysce Biosciences Inc (NASDAQ: ENSC) Share Price, ENSC Stock News, ENSC Share Price & Updates Kalkine | View source ↗ | Kalkine | Aug 5, 2026 | neutral | 0 | 0.6 |
| Ensysce Biosciences (NASDAQ:ENSC) surges 48%, still faces 141% climb for Nasdaq $1 threshold - TechStock² | Ensysce Biosciences (NASDAQ:ENSC) surges 48%, still faces 141% climb for Nasdaq $1 threshold TechStock² | View source ↗ | TechStock² | Aug 4, 2026 | neutral | 0 | 0.6 |
| The Bull Lives Below $1: PRSO, ENSC, TNMG, QNME Stocks to Watch - Barchart.com | The Bull Lives Below $1: PRSO, ENSC, TNMG, QNME Stocks to Watch Barchart.com | View source ↗ | Barchart.com | Aug 4, 2026 | neutral | 0 | 0.6 |
| Ensysce Biosciences Receives Final $5.3 Million NIDA Funding Installment for PF614-MPAR Development - Yahoo Finance | Ensysce Biosciences Receives Final $5.3 Million NIDA Funding Installment for PF614-MPAR Development Yahoo Finance | View source ↗ | Yahoo Finance | Jul 14, 2026 | neutral | 0 | 0.6 |
| Ensysce starts final PF614-MPAR study stage for overdose-protection opioid - Stock Titan | Ensysce starts final PF614-MPAR study stage for overdose-protection opioid Stock Titan | View source ↗ | Stock Titan | Jun 26, 2026 | neutral | 0 | 0.6 |
| ENSC Should I Buy - Intellectia AI | ENSC Should I Buy Intellectia AI | View source ↗ | Intellectia AI | Feb 14, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.